Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients

  • Cha, J.-J.; 
  • Hong, S.J.; 
  • Kim, J.H.; 
  • Lim, S.; 
  • Joo, H.J.; 
  • ... Lee, S.Y.; 
  • 외 27명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Background: Diabetes mellitus (DM) is a critical risk factor for the pathogenesis and progression of coronary artery disease, with a higher prevalence of complex coronary artery disease, including bifurcation lesions. This study aimed to elucidate the optimal stenting strategy for coronary bifurcation lesions in patients with DM. Methods: A total of 905 patients with DM and bifurcation lesions treated with second-generation drug-eluting stents (DES) from a multicenter retrospective patient cohort were analyzed. The primary outcome was the 5-year incidence of target lesion failure (TLF), which was defined as a composite of cardiac death, target vessel myocardial infarction, and target lesion revascularization. Results: Among all patients with DM with significant bifurcation lesions, 729 (80.6%) and 176 (19.4%) were treated with one- and two-stent strategies, respectively. TLF incidence differed according to the stenting strategy during the mean follow-up of 42 ± 20 months. Among the stent strategies, T- and V-stents were associated with a higher TLF incidence than one-stent strategy (24.0 vs. 7.3%, p < 0.001), whereas no difference was observed in TLF between the one-stent strategy and crush or culotte technique (7.3 vs. 5.9%, p = 0.645). The T- or V-stent technique was an independent predictor of TLF in multivariate analysis (hazard ratio, 3.592; 95% confidence interval, 2.117–6.095; p < 0.001). Chronic kidney disease, reduced left ventricular ejection fraction, and left main bifurcation were independent predictors of TLF in patients with DM. Conclusion: T- or V-stenting in patients with DM resulted in increased cardiovascular events after second-generation DES implantation. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT03068494?term=03068494&draw=2&rank=1, identifier: NCT03068494. Copyright © 2022 Cha, Hong, Kim, Lim, Joo, Park, Yu, Kang, Kim, Gwon, Chun, Hur, Han, Rha, Chae, Jeong, Heo, Yoon, Park, Hong, Doh, Cha, Kim, Lee, Chang, Hwang, Choi, Jeong, Song, Choi, Nam, Koo and Lim.

키워드

clinical outcome; coronary bifurcation angioplasty; diabetes mellitus; percutaneous coronary intervention (complex PCI); second-generation drug-eluting stent; stent strategy; CORONARY STENTS; METAANALYSIS; DISEASE; LESIONS; IMPACT
제목
Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
저자
Cha, J.-J.; Hong, S.J.; Kim, J.H.; Lim, S.; Joo, H.J.; Park, J.H.; Yu, C.W.; Kang, J.; Kim, H.-S.; Gwon, H.-C.; Chun, W.J.; Hur, S.-H.; Han, S.H.; Rha, S.-W.; Chae, I.-H.; Jeong, J.-O.; Heo, J.H.; Yoon, J.; Park, J.-S.; Hong, M.-K.; Doh, J.-H.; Cha, K.S.; Kim, D.-I.; Lee, S.Y.; Chang, K.; Hwang, B.-H.; Choi, S.-Y.; Jeong, M.H.; Song, Y.B.; Choi, K.H.; Nam, C.-W.; Koo, B.-K.; Lim, D.-S.
DOI
10.3389/fcvm.2022.1018802
발행일
2022-12
유형
Article
저널명
Frontiers in Cardiovascular Medicine
권
9

파일 다운로드

Thumbnail